COMPARATIVE STUDY
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Reactive psychosis and mortality.

Reactive psychosis is generally thought of as a nosological term of favourable course and outcome. Studies of mortality risk following this psychosis are sparse and inconclusive. This study shows that using mortality as an index of outcome, first-admitted patients with reactive psychosis have as poor an outcome as patients with the endogenous psychoses schizophrenia and manic-depressive psychosis, and thus an excess mortality risk compared with that of the population in general. Reactive depressed patients have even a higher relative mortality risk than endogenous depressed patients. Certain precautions are attached to the use of diagnostic classification of first admissions and especially for reactive psychosis. But as this is a commonly used diagnostic term in Scandinavian psychiatry, the high relative mortality risk is notable. In the search for methods of prevention, the cause of death will be examined in future studies.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app